FERMENTA
Composite scorecard: 49/100 — Quality 69 · Valuation 22
| Share price | ₹443.90 |
| P/B ratio | 2.9 |
| ROE | 18.5% |
| Book value | ₹140.98 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹525 Cr | ₹70 Cr | 19.0% |
| 2025 | ₹468 Cr | ₹76 Cr | 25.0% |
| 2024 | ₹335 Cr | ₹-24 Cr | 8.0% |
| 2023 | ₹349 Cr | ₹-53 Cr | 5.0% |
| 2022 | ₹397 Cr | ₹15 Cr | 16.0% |
Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, pr